Is It Time for Algorism in Clinical Procedure of Surgical Treatment of Type 2 Diabetes as a Component of Metabolic Syndrome?

Przeglad Gastroenterologiczny - Poland
doi 10.5114/pg.2013.34180
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Termedia Sp. z.o.o.

Related search

Steroid-Induced Diabetes: Is It Just Unmasking of Type 2 Diabetes?

ISRN Endocrinology
2012English

Prevention of Type 2 Diabetes: What Is It Really?

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2003English

Is Central Obesity a Good Predictor of Carotid Atherosclerosis in Japanese Type 2 Diabetes With Metabolic Syndrome?

Endocrine Journal
EndocrinologyMetabolismDiabetes
2007English

Is It a Supplementary Benefit to Use Anti-Inflammatory Agents in the Treatment of Type 2 Diabetes?

BMC Research Notes
BiochemistryMedicineGeneticsMolecular Biology
2017English

Clinical Inertia in Individualising Care for Diabetes: Is There Time to Do More in Type 2 Diabetes?

Diabetes Therapy
Internal MedicineEndocrinologyMetabolismDiabetes
2014English

Canagliflozin Improves Risk Factors of Metabolic Syndrome in Patients With Type 2 Diabetes Mellitus and Metabolic Syndrome

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Internal MedicinePharmacology
2017English

Type-2 Diabetes Mellitus Is It Habitat Specific?

IOSR Journal of Pharmacy and Biological Sciences
2014English

Metabolic Syndrome; Agreement Between Metabolic Syndrome Diagnostic Criteria Among Type 2 Diabetes Mellitus Patients

THE PROFESSIONAL MEDICAL JOURNAL
2017English

Osteoprotegerin Is Independently Associated With Metabolic Syndrome and Microvascular Complications in Type 2 Diabetes Mellitus

Diabetes and Vascular Disease Research
Internal MedicineCardiologyEndocrinologyCardiovascular MedicineMetabolismDiabetes
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy